129 related articles for article (PubMed ID: 2448023)
1. Kinetics of methotrexate and its metabolites in red blood cells.
Lena N; Imbert AM; Brunet P; Cano JP; Carcassonne Y
Cancer Drug Deliv; 1987; 4(2):119-27. PubMed ID: 2448023
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate and its polyglutamate derivatives in erythrocytes during and after weekly low-dose oral methotrexate therapy of children with acute lymphoblastic leukemia.
Schrøder H; Fogh K
Cancer Chemother Pharmacol; 1988; 21(2):145-9. PubMed ID: 2450690
[TBL] [Abstract][Full Text] [Related]
3. In vivo methotrexate kinetics and metabolism in human hematopoietic cells. Clinical significance of methotrexate concentrations in erythrocytes.
Schrøder H
Dan Med Bull; 1990 Feb; 37(1):22-40. PubMed ID: 2178886
[TBL] [Abstract][Full Text] [Related]
4. Role of polyglutamates in methotrexate action.
Wilmanns W; Schalhorn A
Chemioterapia; 1985 Oct; 4(5):349-53. PubMed ID: 2416481
[TBL] [Abstract][Full Text] [Related]
5. In vivo decline of methotrexate and methotrexate polyglutamates in age-fractionated erythrocytes.
Schrøder H; Fogh K; Herlin T
Cancer Chemother Pharmacol; 1988; 21(2):150-5. PubMed ID: 2450691
[TBL] [Abstract][Full Text] [Related]
6. HPLC determination of erythrocyte methotrexate polyglutamates after low-dose methotrexate therapy in patients with rheumatoid arthritis.
Dervieux T; Orentas Lein D; Marcelletti J; Pischel K; Smith K; Walsh M; Richerson R
Clin Chem; 2003 Oct; 49(10):1632-41. PubMed ID: 14500588
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of methotrexate polyglutamates in lymphoblast preparations from bone marrow and blood, and the contribution of residual red blood cells.
Weigand M; Frei E; Graf N; Wiessler M
J Cancer Res Clin Oncol; 2000 Jul; 126(7):407-11. PubMed ID: 10929763
[TBL] [Abstract][Full Text] [Related]
8. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
[TBL] [Abstract][Full Text] [Related]
9. Prediction of the therapeutic response to methotrexate at 24 weeks by methotrexate-polyglutamates concentration in erythrocytes at 8 weeks in patients with rheumatoid arthritis.
Murosaki T; Nagatani K; Sato T; Akiyama Y; Ushijima K; Lefor AK; Fujimura A; Minota S
Mod Rheumatol; 2017 May; 27(3):411-416. PubMed ID: 27435295
[TBL] [Abstract][Full Text] [Related]
10. Effect of total glucosides of paeony and Tripterygium wilfordii polyglycosides on erythrocyte methotrexate polyglutamates in rats, analysed using ultra-high-performance liquid chromatography-tandem mass spectrometry.
Wu S; Mo L; Ye C; Xun T; Wang X; Lv B; Zhan X; Liu B; Ding Q; Peng J; Chen C; Yang X
J Pharm Pharmacol; 2021 Jul; 73(8):1039-1048. PubMed ID: 33749788
[TBL] [Abstract][Full Text] [Related]
11. A short-chain methotrexate polyglutamate as outcome parameter in rheumatoid arthritis patients receiving methotrexate.
Hobl EL; Jilma B; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Rizovski B; Mader RM
Clin Exp Rheumatol; 2012; 30(2):156-63. PubMed ID: 22152098
[TBL] [Abstract][Full Text] [Related]
12. Assessment of intracellular methotrexate and methotrexate-polyglutamate metabolite concentrations in erythrocytes by ultrafast matrix-assisted laser desorption/ionization triple quadrupole tandem mass spectrometry.
Meesters RJ; den Boer E; de Jonge R; Lindemans J; Luider TM
Rapid Commun Mass Spectrom; 2011 Oct; 25(20):3063-70. PubMed ID: 21953961
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intracellular methotrexate kinetics in red blood cells with the kinetics in other cell types.
Korell J; Duffull SB; Dalrymple JM; Drake J; Zhang M; Barclay ML; Stamp LK
Br J Clin Pharmacol; 2014 Mar; 77(3):493-7. PubMed ID: 23844933
[TBL] [Abstract][Full Text] [Related]
14. Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations.
Becker ML; van Haandel L; Gaedigk R; Lasky A; Hoeltzel M; Stobaugh J; Leeder JS
Arthritis Rheum; 2010 Jun; 62(6):1803-12. PubMed ID: 20191581
[TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatography separation of aminopterin-polyglutamates within red blood cells of children treated for acute lymphoblastic leukemia.
Vijayanathan V; Smith AK; Zebala JA; Kamen BA; Cole PD
Transl Res; 2007 Dec; 150(6):367-73. PubMed ID: 18022599
[TBL] [Abstract][Full Text] [Related]
16. Determination of erythrocyte methotrexate polyglutamates by liquid chromatography/tandem mass spectrometry after low-dose methotrexate therapy in Chinese patients with rheumatoid arthritis.
Mo X; Wen Y; Ren B; Chen J; Xu C; Wang X; Huang M; Chen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 907():41-8. PubMed ID: 22999476
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, retention, and biological activity of methotrexate polyglutamates in cultured human breast cancer cells.
Jolivet J; Schilsky RL; Bailey BD; Drake JC; Chabner BA
J Clin Invest; 1982 Aug; 70(2):351-60. PubMed ID: 6178756
[TBL] [Abstract][Full Text] [Related]
18. Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase.
Jolivet J; Chabner BA
J Clin Invest; 1983 Sep; 72(3):773-8. PubMed ID: 6193143
[TBL] [Abstract][Full Text] [Related]
19. High-performance liquid chromatographic analysis of MTX, 7-OH-MTX and MTX derivatives: application to intracellular metabolism in tumor cells (HT 29).
Durand R; Fabre G; Cano JP; Catalin J; Ahmed OA; Just S
J Appl Toxicol; 1983 Aug; 3(4):189-95. PubMed ID: 6196390
[TBL] [Abstract][Full Text] [Related]
20. Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology.
Schmiegelow K; Schrøder H; Gustafsson G; Kristinsson J; Glomstein A; Salmi T; Wranne L
J Clin Oncol; 1995 Feb; 13(2):345-51. PubMed ID: 7531219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
